Webinars
Why FISH for ALK Testing (and PCR for EGFR and KRAS) in NSCLC?
Category: Webinar
Description: Aurelia Meloni-Ehrig, PhD discussed current mutation testing guidelines and best practices for patients with NSCLC, compares and contrasts ALK testing methodologies and discusses the advantages offered by FISH for ALK mutation status testing.
Content overview:
• Describe genetic aberrations (eg, EGFR, KRAS, ALK) associated with patients with NSCLC and the impact they have on individualized disease management
• Communicate current guidelines and best practices for NSCLC mutation testing
• Discuss the potential clinical benefits associated with ordering an NSCLC-specific mutation panel, rather than individual assays
• Compare and contrast ALK testing methodologies and communicate the advantages offered by FISH
Related Content
Presentation:
Advances in Thyroid Cancer Diagnosis and Monitoring
Reitz, Richard, MD
Waldman, Frederic, MD, PhD
Expert Insight:
Lung Cancer Testing: Why FISH for ALK Testing in NSCLC?
Meloni-Ehrig, Aurelia, PhD, DSc
Expert Insight:
Targeting Lung Cancer
Govindan, Ramaswamy, MD
